En español

NIDA and AstraZeneca partner to develop potential addiction medication


May 10, 2013

From concept to medication to treatment graphic

NIDA and AstraZeneca, a global research-based biopharmaceutical company, have joined efforts to explore a novel medication to treat drug addiction. The scientific partnership will explore a specific molecule that modulates the activity of glutamate – an excitatory neurotransmitter. Preclinical studies with this class of molecule indicate that it could be effective for treating a range of mental disorders, including abuse of substances ranging from tobacco to cocaine.

A key strategy of NIDA’s medications development program is to work with pharmaceutical and biotechnology companies to translate basic research findings into medications that treat drug addiction. Further details on NIDA’s efforts in this area can be found at: www.drugabuse.gov/about-nida/organization/divisions/division-pharmacotherapies-medical-consequences-drug-abuse-dpmcda.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245.

NIDA Press Office

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases








Get this Publication

    Cite this article

    NIDA. (2013, May 10). NIDA and AstraZeneca partner to develop potential addiction medication. Retrieved from https://www.drugabuse.gov/news-events/news-releases/2013/05/nida-astrazeneca-partner-to-develop-potential-addiction-medication

    press ctrl+c to copy
    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science